Successful treatment with ixekizumab of lower-limb linear psoriasis in a child

Ann Dermatol Venereol. 2022 Sep;149(3):216-218. doi: 10.1016/j.annder.2022.02.003. Epub 2022 Mar 10.
No abstract available

Keywords: Anti-interleukin 17A biologic agent; Child; Linear psoriasis.

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Child
  • Dermatologic Agents* / therapeutic use
  • Humans
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • ixekizumab